Area of research
Genetics · Immunology
Research interest
Research interests include Medicine, Inflammatory bowel disease, Internal medicine, Infliximab, Ulcerative colitis, and Antibiotics.
Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN
Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN
Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN
Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn’s Disease: A Nationwide Analysis from the epi-IIRN Cohort
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN
Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A Population-Based Study with Fifty Years of Follow-Up
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN